Hong‐Min Liu
- Organic Chemistry top 1%
- Quinazolinone synthesis and applications 21
- Synthesis and Biological Evaluation 21
- Synthesis and biological activity 18
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 50
- Histone Deacetylase Inhibitors Research 38
- Ubiquitin and proteasome pathways 27
- Cancer-related gene regulation 26
- Cancer therapeutics and mechanisms 22
- Oncology top 2%
- Toxicology top 2%
- Molecular Medicine top 5%
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)Circulation Research (1 paper)
- Partner nations
- ChinaNew ZealandUnited States
In The Last Decade
Hong‐Min Liu
259 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Organic Chemistry 1.6k
- Molecular Biology 3.5k
- Oncology 1.2k
- Toxicology 119
- Molecular Medicine 168
Countries citing papers authored by Hong‐Min Liu
This map shows the geographic impact of Hong‐Min Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Min Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Min Liu more than expected).
Fields of papers citing papers by Hong‐Min Liu
This network shows the impact of papers produced by Hong‐Min Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Min Liu. The network helps show where Hong‐Min Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hong‐Min Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 20 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 17 | |
| 11 | 2023 | 23 | |
| 12 | 2023 | 36 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 18 | |
| 15 | 2022 | 24 | |
| 16 | 2022 | 5 | |
| 17 | 2020 | 48 | |
| 18 | 2020 | 24 | |
| 19 | 2020 | 17 | |
| 20 | 2020 | 213 |
About Hong‐Min Liu
Hong‐Min Liu is a scholar working on Organic Chemistry, Molecular Biology and Oncology, having authored 266 papers that have together received 5.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (50 papers), Histone Deacetylase Inhibitors Research (38 papers), Ubiquitin and proteasome pathways (27 papers), Cancer-related gene regulation (26 papers), Cancer therapeutics and mechanisms (22 papers), Quinazolinone synthesis and applications (21 papers), Synthesis and Biological Evaluation (21 papers) and Synthesis and biological activity (18 papers). The work is most often cited by research in Organic Chemistry (1.6k citations), Molecular Biology (3.5k citations) and Oncology (1.2k citations). Hong‐Min Liu has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Yi‐Chao Zheng, Bin Yu, Zhe‐Sheng Chen, Xiaojing Shi, Liying Ma, Dandan Shen, Jinlian Ma, Shuo Yuan, Ying Liu and Bo Wang. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.